Related Experiment Video
Updated: Jun 12, 2025

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
The Relationship Between Fibrinogen and Glycated Hemoglobin (HbA1c) in Diabetic Foot Ulcers
Kiran Notu1, Jayakumar Kt1, Raji Rajesh Lenin2
1General Medicine, Sri Ramaswamy Memorial (SRM) Medical College Hospital and Research Centre, Kattankulathur, IND.
Insights
Fibrinogen levels correlate with glycated hemoglobin (HbA1c) and predict glycemic control in diabetic foot ulcers (DFUs). This simple estimation aids in managing DFU patients and assessing peripheral arterial disease risk.
Area of Science:
- Endocrinology
- Vascular Medicine
- Clinical Chemistry
Background:
- Diabetic foot ulcers (DFUs) significantly impact patient quality of life and prognosis.
- Effective management requires understanding complications like poor glycemic control and peripheral arterial disease.
Purpose of the Study:
- To assess the correlation between fibrinogen and glycated hemoglobin (HbA1c) in DFU patients at 1 and 6 months.
- To compare fibrinogen levels with the Wagner classification and ankle-brachial index (ABI) in DFU patients.
Main Methods:
- Observational study of 50 DFU patients.
- Collected blood samples for HbA1c, serum fibrinogen, hemoglobin, and WBC counts.
- Analyzed data using ANOVA and Pearson's correlation.
Main Results:
- Significant differences observed between fibrinogen and HbA1c levels (p < 0.0001).
- Strong association found between fibrinogen levels and ABI scores (p < 0.0001).
- Significant differences in fibrinogen noted at 1 and 6 months concerning HbA1c and ABI.
Conclusions:
- Fibrinogen is a potential early marker for glycemic control in DFU patients.
- Fibrinogen levels correlate with peripheral arterial disease markers (ABI).
- Simple fibrinogen estimation can aid in predicting glycemic control and managing DFU complications.
Introduction:
Diabetic foot ulcers (DFUs) are a common complication of diabetes that affects patients' quality and prognosis of life. The study aims to assess the correlation between fibrinogen and glycated hemoglobin (HbA1c) in DFUs at the first and sixth months and to compare fibrinogen levels with Wagner classification in DFU patients.
Methods:
This observational study was conducted at SRM Medical College Hospital and Research Centre from January 2021 to July 2022. Fifty diabetes patients with DFUs were selected, and informed consent was obtained before the study started. Blood samples were collected from all the participants for HbA1C, serum fibrinogen, hemoglobin, and white blood cells. In this study, data were entered into MS Excel (Microsoft Corporation, Redmond, WA) and analyzed using SPSS version 24 (IBM Corp., Armonk, NY). ANOVA and Pearson's correlation were used to examine the relationships between serum fibrinogen levels and clinical parameters.
Results:
Among 50 patients, the females were 16 (32%), and the males were 34 (68%). Most patients (34%) were in the 56-60 age group. Twenty patients had diabetes for 10 years, and 24 were diabetic for 11-15 years. The ankle-brachial index (ABI score) was mild in 14 patients (28%), moderate in 28 patients (56%), and normal in eight patients (16%). There is a significant difference in comparison between the Wagner classification and ABI. A significant difference was observed in fibrinogen at the first and sixth months between HbA1c first, third, and sixth months. Significant differences were also observed in fibrinogen and ABI in the first and sixth months.
Conclusion:
Key findings include significant differences between fibrinogen and HbA1c levels (p < 0.0001) and a strong association between fibrinogen levels and ABI scores (p < 0.0001), underscoring fibrinogen's potential as an early marker for glycemic control and peripheral arterial disease in DFU patients. We concluded that simple fibrinogen estimation helps predict glycemic control in diabetic patients with DFUs.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Proteoglycans
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hypoglycemia and Glucagon

